Parameters of liver prooxidative-antioxidant system in cases of experimental antiphospholipid syndrome and l-arginin administration
DOI:
https://doi.org/10.11603/mcch.2410-681X.2017.v0.i3.8143Keywords:
antiphospholipid syndrome, liver, oxidative stress, antioxidant system, mitochondrial enzymes.Abstract
Introduction. Antiphospholipid syndrome (APS) that is developed due to underlying autoimmune mechanism often causes miscarriage, vessels thrombosis of different localization, cerebrovascular accident, cardiovascular and other diseases that are accompanied by significant activation of free radical processes. Pathogenesis of liver damage in cases of APS has not been adequately studied.
The aim of the study – to establish the changes in parameters of prooxidative-antioxidant system and tissue respiration in liver in cases of experimental antiphospholipid syndrome and L-arginine administration.
Research Methods. Mice of BALB/c line were used in the research. The APS was modeled using cardiolipin emulsified in 75 complete Freund's adjuvant; subsequent injections were administered with incomplete Freund's adjuvant. Cardiolipin was injected intramuscularly four times at a dose of 30 µg per 1 injection with 14-day intervals between the injections. For correction, L-arginine hydrochloride (25 mg/kg) was administered once daily during 10 days after APS development.
The activity and content of antioxidant system components (superoxide dismutase, catalase, reduced glutathione) were investigated in liver tissue. The level of lipid peroxidation products was determined by the content of lipid hydroperoxides and TBA-active products. The state of energy-supplying processes of mitochondria was studied due to the activity of succinate dehydrogenase and cytochrome oxidase. The concentration of proteins was determined by Lowry method.
Results and Discussion. In cases of APS in liver the imbalance in functioning of prooxidative antioxidant system (increased activity of superoxide dismutase and catalase, decrease in the content of reduced glutathione, increase in the level of lipids hydroperoxides, TBA-active products), of mitochondrial electron transport chain (decrease in the activity of succinate dehydrogenase, cytochrome oxidase) in cases of experimental antiphospholipid syndrome was evidenced. In cases of experimental APS in presence of L-arginine administration, the re-establishment of activity and content of antioxidant system components, enzymes of mitochondrial electron transport chain, decrease in content of lipid hydroperoxides and TBA-active products in liver was proved.
Conclusion. In cases of experimental antiphospholipid syndrome, L-arginine, in the event of its repeated administration, reduces manifestations of oxidative stress and reactivate enzymes of mitochondrial electron transport chain in liver tissue of BALB/c mice.References
Nasonov, E.L. (2004). Antifosfolipidnyi sindrom – Antiphospholipid syndrome. M.: Litterra [in Russian].
Iakubovska, I.O., & Henyk S.I. (2008). Antyfosfolipidnyi syndrom (syndrom Khiuza) v likarskii praktytsi. Chastyna 1 [Antiphospholipid syndrome (Hughes syndrome) in medical practice. Part 1]. Klinichna imunolohiia. Alerholohiia. Infektolohiia – Clinical immunology. Allergology. Infectology, 4, 31-36 [in Ukrainian].
Gornitckaia, O.V. (2008). Antifosfolipidnyi sindrom [Antiphospholipid syndrome]. Eksperimentalna ta klіnіchna fіzіologіia ta bіokhіmіia – Experimental and clinical physiology and biochemistry, 1(4), 61-70 [in Russian].
Alarcon-Segovia, D., Perez-Ruiz, A., & Vila A.R. (2000). Long-term prognosis of antiphospholipid syndrome in patients with systemic lupus erythematosus. J. Autoimmunity, 15, 157-163.
Hushcha, O.V. (2006). Antyfosfolipidnyi syndrom: istoriia, suchasnist i perspektyvy [Antiphospholipid syndrome: history, present and future]. Ukr. zhurnal nefrolohii ta dializu – Ukr. journal of nephrology and dialysis, 4, 69-75 [in Ukrainian].
Shcherbakova, M.Iu., Reshetniak, T.M., & Zhdanova L.V. (2008). Antifosfolipidnyi sindrom u detei s somaticheskoi patologiei [Antiphospholipid syndrome in children with somatic pathology]. Pediatriia – Pediatrics, 87 (4), 119-124 [in Russian].
Chernyshov, A.V., Talko, V.V., & Andreichenko S.V. (2013). Sovremennye voprosy patogeneza i diagnostiki antifosfolipidnogo sindroma: (obzor literatury) [Modern issues of pathogenesis and diagnosis of antiphospholipid syndrome: (review)]. Ukr. med. Chasopis – Ukr. med. Journal, 1, 122-125 [in Russian].
Rand, J.H. (2002). Molecular pathogenesis of the antiphospholipid syndrome. Circulation Research, 90, 29-37.
Zhang, Q., Ye, D.Q., Chen, G.P., & Zheng, Y. (2010). Oxidative protein damage and antioxidant status in systemic lupus erythematosus. Clin. Exp. Dermatol, 35 (3), 287-294.
Perricone, C., Carolis, C.De, & Perricone, R. (2009). Glutathione: a key player in autoimmunity. Autoimmun. Rev, 8 (8), 697-701.
Perez-Sanchez, C., Ruiz-Limon, P., & Aguirre, M.A. (2012). Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q10 treatment. Blood, 119 (24), 5859-5870.
Iuliano, L., Practico, D., & Ferro D. (1997). Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies. Blood, 90 (10), 3931-3935.
Alves, J.D., Mason, L.J., & Ames P.R.J. (2005). Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model. Rheumatology, 44, 1238-1244.
Ames, P.R., Matsuura, E., & Batuca J.R. (2010). High density lipoprotein inversely related to its specific autoantibody favouring oxidation in thrombotic primary antiphospholipid syndrome. Lupus, 19 (6), 711-716.
Pauzner, R., Dulitzky, M., Carp, H., Mayan, H., Kenett, R., Farfel, Z., & Many A. (2003). Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome. Journal of Thrombosis and Haemostasis, 1, 1758-1763.
Golubova, O. A. (2007). Porazhenie pecheni pri antifosfolipidnom sindrome [Defeat of the liver under antiphospholipid syndrome]. Mistetctvo lіkuvannia – The art of treatment, 3, 35-41 [in Russian].
Alves, J.D., & Grima, B. (2003). Oxidative stress in systemic lupus erythematosus and antiphospholipid syndrome: a gateway to atherosclerosis. Curr. Rheumatol. Rep, 5 (5), 383-390.
Zaichenko, H.V., Lar’ianovska, Iu.B., & Deieva, T.V. (2011). Morfolohichnyi stan matky ta platsenty pry eksperymentalnomu modeliuvanni hestatsiinoho antyfosfolipidnoho syndromu na myshakh [Morphological state of the uterus and placenta in experimental modeling of gestational antiphospholipid syndrome in mice]. Ukrainskyi medychnyi almanakh – Ukrainian Medical Journal, 14 (4), 136-141 [in Ukrainian].
Kamyshnikov V.S. (2004). Spravochnik po kliniko–biokhimicheskim issledovaniiam i laboratornoi diagnostike – Manual on Clinical Biochemical Research and Laboratory Diagnostics. M.: MEDpress–inform [in Russian].
Chevari, S., Chaba, I., & Sekei, I. (1985). Rol superoksiddismutazy v okislitelnykh protcessakh kletki i metod opredeleniia ee v biologicheskikh materialakh [The role of superoxide dismutase in the oxidative processes of the cell and the method for its determination in biological materials]. Lab. delo – Lab. work, 11, 678-681 [in Russian].
Koroliuk, M.A., Ivanova, L.I., & Maiorova, I.G. (1988). Metod opredeleniia aktivnosti katalazy [Method for determining the activity of catalase ]. Lab. delo – Lab. work, 1, 16-19 [in Russian].
Ellman, G.L. (1959). Tissue sulfhydryl groups. Arch. Biochem. Biophys, 82, 70-77.
Gavrilov, V.B., & Mishkorudnaia, M.I. (1983). Spektrofotometricheskoe opredelenie soderzhaniia gidroperekisei lipidov v plazme krovi [Spectrophotometric determination of the content of lipids hydroperoxides in blood plasma]. Lab. delo – Lab. work, 3, 33-35 [in Russian].
Andreeva, L.I., Kozhemiakin, L.A., & Kishkun, A.A. (1988). Modifikatciia metoda opredeleniia perekisei lipidov v teste s tiobarbiturovoi kislotoi [Modification of the method for determining lipid peroxides in a test with thiobarbituric acid] Lab. delo – Lab. work, 11, 41-43 [in Russian].
Eshchenko, N.D., & Volskii G.G. (1982). Opredelenie kolichestva iantarnoi kisloty i aktivnosti suktcinatdegidrogenazy [Determination of amber acid and succinate dehydrogenase activity]. Metody biokhimicheskikh issledovanii – Methods of Biochemical Research, pp. 207-210. L.: Izd-vo Leningradskogo universiteta [in Russian].
Krivchenkova, R.S. (1977). Opredelenie aktivnosti tcitokhromoksidazy v suspenzii mitokhondrii [Determination of the activity of cytochrome oxidase in suspension of mitochondria]. Sovremennye metody v biokhimii – Modern methods in biochemistry. Pod red. V.N. Orekhovicha. – M.: Meditcina [in Russian].
Lowry, О.М., Rosebrough, N.J., Farr, A.L., & Randall, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193 (1), 265-275.
Kolisnyk, M.I., Kolisnyk, H.V., & Nidzyulka, Y.E. (2009). Aktyvni formy kysniu ta yikh rol u metabolizmi klityn [Active forms of oxygen and their role in cell metabolism]. Biolohiia tvaryn. – Biology of animals, 1-2, 59-70 [in Ukrainian].
Segal, B.M., Thomas, W., Zhu, X., Diebes, A., McElvain, G., Baechler, E., & Gross, M. (2012). Oxidative stress and fatigue in systemic lupus erythematosus. Lupus, 21, 984-992.
Meshchyshen, I.F. (1999). Hlutationova systema orhanizmu za umov normy ta patolohii – Glutathione system of the organism in conditions of normal and pathology. Chernivtsi: Medakademiia [in Ukrainian].
